Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib (PazoQoL)
Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib - a Randomized, Controlled Trial
Sponsor: GWT-TUD GmbH
Terminated
problems with recruiting
Other terminated trials from GWT-TUD GmbH
- Leukemia, Myeloid, Chronic-Phase · Phase PHASE2 · Aug 2023
- Endothelial Function · Jul 2019
- Acute Myeloid Leukemia (AML) · Phase PHASE2 · Oct 2018
- Diabetes Mellitus Type 2 · Phase PHASE4 · Jan 2017
- Critical Limb Ischemia · Jul 2013
More terminations from GWT-TUD GmbH
Other Soft Tissue Sarcoma Adult trials with similar outcome
Listed as NCT03735758, this PHASE4 trial focuses on Soft Tissue Sarcoma Adult and remains terminated or withdrawn. Sponsored by GWT-TUD GmbH, it has been updated 8 times since 2018, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Oct 2021 — Jul 2024 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE4
▶ Show 3 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Oct 2019 — Sep 2020 [monthly]
Recruiting PHASE4
-
Dec 2018 — Oct 2019 [monthly]
Recruiting PHASE4
First recorded
Nov 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- GWT-TUD GmbH
For direct contact, visit the study record on ClinicalTrials.gov .